Down 54%, Is AppLovin Still a Millionaire-Maker Stock?
AppLovin (NASDAQ: APP) made some opportunistic investors a lot of money over the past few years.
Industry
C3.ai CEO Thomas Siebel Sells Over 444,000 Shares Worth $4.8 Million After a 40% Decline in the Stock
The notable CEO sold ~444,000 shares at a weighted average price of $10.77 per share, representing a total transaction value of ~$4.8 million.
Robinhood Stock Once Fell 82% Below Its IPO Price. $10,000 Invested at the IPO Has Still More Than Tripled.
Robinhood priced its IPO at $38 a share, and the stock closed as low as $6.89 in June 2022.
Coca-Cola Hasn't Sold Much More Soda in a Decade. Its Dividend Has Gone Up Every Year Anyway.
The Coca-Cola system sold 33.8 billion unit cases of drinks in 2025, about 16% more than it sold in 2015.
Soybeans Rally Off Early Lows as Traders Eye Monday Trade Announcement
Soybeans came back to close Friday with contracts down 1 ¾ cent in some back months to November’s 1 ½ cent gain. Trade details set to be announced Monday calmed the selling. November saw 15 ½ cent gain on the week. The …
Corn Rallies off Early Lows on Friday with Trade Details to Come Monday
Corn futures found strength throughout the Friday session, as contracts closed 10-15 cents off the early lows and steady to a penny higher. December managed to post a ¾ cent gain on the week. The CmdtyView national aver…
Dollar Falls as Crude Prices Decline and Stocks Gain
The dollar index (DXY00) fell by -0.32% on Friday. The dollar was under pressure Friday after WTI crude oil prices fell more than -2%, easing inflation expectations and weighing on Fed policy. Also, strength in stocks o…
Bill Gates Calls For Federal Regulation Of Artificial Intelligence Development
(RTTNews) - Microsoft Corporation (MSFT) co-founder Bill Gates has called for federal legislation to regulate the development of artificial intelligence, arguing that self-regulation by AI companies is not sufficient to…
Stock Market Today, Sept. 25: Tesla Stock Under Pressure Despite Plans to Ramp Semi Truck Production
Tesla (NASDAQ:TSLA), the global electric-vehicle, battery storage, and autonomous driving systems company, closed at $372.11, down 1.54%. Analyst cuts overshadowed plans for Tesla's Semi Truck production ramp. Trading v…
Tesla Begins Delivering Long-Delayed Semi Trucks After Nearly A Decade
(RTTNews) - Tesla (TSLA) has begun handing over its first all-electric Semi trucks to customers, nearly a decade after the vehicle was unveiled in 2017. The company held an event at its new Semi factory in Reno, Nevada,…
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?
AbbVie is transitioning its revenue base toward newer immunology drugs to offset the decline of its legacy treatments.
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product?
Novo Nordisk needs new products to better compete with Eli Lilly in the weight loss market.
Stocks Supported by Lower Crude Prices and Strength in Chipmakers
The S&P 500 Index ($SPX) (SPY) is up by +0.25% today, the Dow Jones Industrial Average ($DOWI) (DIA) is up by +0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.30%. December E-mini S&P futures (ESZ26) are up +0.25…
Why Paychex Stock Slumped This Week
Paychex (NASDAQ: PAYX) may not be a household name for investors, but it is a closely watched company as an indicator of the strength in small and mid-sized businesses. Paychex provides payroll, human resources, and ben…
3 Steps to Avoid Running Out of Money in Retirement
Many pre-retirees worry that once they stop working and age, they'll face health issues, boredom, and social isolation. But there's one fear you can't ignore in the course of your retirement planning: running out of mon…
Dollar Weakness Spurs Short Covering in Coffee Futures
Coffee prices are climbing today, with arabica posting a 1-week high. Today’s slide in the dollar index ($DXY) has sparked fund short covering in coffee futures.
Crude Prices Slip in Hopes of Diplomacy Reopening the Strait of Hormuz
November WTI crude oil (CLX26) is down -0.58 (-0.61%) today, and November RBOB gasoline (RBX26) is down -0.0826 (-2.48%).
Wheat Falling Lower on Friday with Black Sea Pressure
Wheat is under pressure to start Friday, with the three exchanges down 12 to 20 cents. The wheat complex saw some pressure on Thursday. Chicago SRW saw losses of 1 ½ to 5 ¼ cents at the close. Open interest was down 2,6…
Top Retirement Fears -- and the Straightforward Fixes for Each
Given the state of the economy and geopolitical events beyond their control, it's no surprise that more Americans report feeling anxious about retirement. Among their top fears are healthcare costs and outliving their r…
AllianceBernstein Appoints Onur Erzan To Succeed Seth Bernstein As President & CEO
(RTTNews) - AllianceBernstein Holding L.P. (AB) and AllianceBernstein L.P. or AB, an investment management firm and a subsidiary of Equitable Holdings, Inc. (EQH), announced Friday the appointment of President Onur Erza…
Wall Street Targets To Bounce Back To Positive Territory
(RTTNews) - Oil prices soared to above $116 a barrel on Friday, after President Trump revealed his plans to seize Iran's Kharg Island that handles 90 percent of Iran's oil export. Iran has been threatening of rain fire …
Stocks Finish Mostly Lower as Bond Yields Soar
The S&P 500 Index ($SPX) (SPY) closed down by -0.02% on Thursday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down by -0.31%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.03%. December E-mini S&P future…
Fate Therapeutics Receives $15M CIRM Grant To Advance FT819 In Lupus Nephritis
(RTTNews) - Fate Therapeutics, Inc. (FATE), a clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies, announced that the California Institute for Regenerative Medicine (CIRM) awarded t…
AstraZeneca's IMFINZI-Enfortumab Regimen Wins FDA Priority Review In Bladder Cancer
(RTTNews) - AstraZeneca plc (AZN) announced that the U.S. FDA has accepted and granted Priority Review to its supplemental Biologics License Application for IMFINZI in combination with enfortumab vedotin (EV) for the tr…